GlaxoSmithKline announces USD 1.65 billion of acquisition Reliant Pharmaceutical
23-Nov-2007
The acquisition is subject to approval by the US Federal Trade Commission and is expected to conclude before year-end.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.